Jun 12 |
Moderna's RSV Vaccine Has 'Ample Opportunity' Despite Seasoned Competitors, Oppenheimer Says
|
Jun 12 |
Moderna announces positive Phase III data for Covid-19/Influenza mRNA vaccine
|
Jun 11 |
Moderna president: Company outlook 'stabilizing' thanks to new flu-COVID vaccine data
|
Jun 11 |
Moderna (MRNA) COVID-Flu Combo Jab Meets Late-Stage Study Goal
|
Jun 10 |
Moderna (MRNA) Stock Sinks As Market Gains: Here's Why
|
Jun 10 |
Moderna Submits Updated COVID-19 Jab to FDA for Review
|
Jun 10 |
Moderna, Inc. (MRNA) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)
|
Jun 10 |
Top Midday Stories: Elliott Amasses $2 Billion Stake in Southwest; SCOTUS to Review Meta Investor Data-Harvesting Suit; Blackstone Competes Tropical Smoothie Acquisition
|
Jun 10 |
Moderna Says Combination Flu And Covid Vaccine Beat Out Rivals From Sanofi, GSK
|
Jun 10 |
Stocks to Watch Monday: Nvidia, Apple, AMD, Southwest Airlines
|